Inmune Bio, Inc.
INMB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001711754
No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Inmune Bio, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Of which not filed for Q4 2025 | Q4 2025 | Change |
|---|---|---|---|---|
| Holders | 73 | 1 | 74 | +2 |
| Shares | 4.66M | 29.2K | 5.08M | +457.4K (+9.9%) |
| Value | $9.64M | $61.6K | $7.93M | −$1.64M (−17.2%) |
1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Inmune Bio, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Dauntless Investment Group, LLC | 304,922 | $475.7K | 1.75% |
| Jain Global LLC | 42,051 | $65.6K | 0.00% |
| Bank of Montreal | 25,987 | $40.5K | 0.00% |
| Two Sigma Securities, LLC | 25,363 | $39.6K | 0.01% |
| Virtu Financial LLC | 20,388 | $32.0K | 0.00% |
| Quadrature Capital Ltd | 16,961 | $26.5K | 0.00% |
| Keating Financial Advisory Services, Inc. | 200 | $312 | 0.00% |
| GAMMA Investing LLC | 181 | $282 | 0.00% |
| Assetmark, Inc | 150 | $234 | 0.00% |
| EverSource Wealth Advisors, LLC | 81 | $126 | 0.00% |
| Essential Partners LLC | 9 | $14 | 0.00% |
| Sunbelt Securities, Inc. | 8 | $12 | 0.00% |
Sold out (10)
Institutions that held Inmune Bio, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Group One Trading, L.P. | 38,584 | $79.9K |
| Cambridge Investment Research Advisors, Inc. | 21,375 | $44.0K |
| Modera Wealth Management, LLC | 15,455 | $32.0K |
| Independent Advisor Alliance | 14,500 | $30.0K |
| SG Americas Securities, LLC | 10,784 | $22.0K |
| Sculptor Capital LP | 6,100 | $12.6K |
| Principal Securities, Inc. | 619 | $1.28K |
| SRS Capital Advisors, Inc. | 490 | $1.01K |
| Cranbrook Wealth Management, LLC | 350 | $725 |
| National Bank of Canada | 200 | $412 |
Not filed for Q4 2025 yet (1)
Institutions that held Inmune Bio, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Wolverine Trading, LLC | 29,193 | $61.6K |